Skip to main content
SpringerLink
Log in

Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data

  • Letter to the Editor
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 13 December 2023

The Original Article was published on 12 May 2023

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ueno M, Fujiwara T, Tokumasu H, et al. Real-world efficacy of antibiotic prophylaxis for upper gastrointestinal bleeding in cirrhotic patients in Japan. J Gastroenterol. 2023;58:766–77.

    Article  CAS  PubMed  Google Scholar 

  2. Trebicka J, Fernandez J, Papp M, et al. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology. J Hepatol. 2020;73:842–54.

    Article  PubMed  Google Scholar 

  3. Liu B, Hadzi-Tosev M, Liu Y, et al. Accuracy of international classification of diseases, 10th revision codes for identifying sepsis: a systematic review and meta-analysis. Crit Care Explor. 2022;4:e0788.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Knol MJ, Janssen KJM, Donders ART, et al. Unpredictable bias when using the missing indicator method or complete case analysis for missing confounder values: an empirical example. J Clin Epidemiol. 2010;63:728–36.

    Article  PubMed  Google Scholar 

Download references

Funding

None.

Author information

Authors and Affiliations

  1. Gastroenterology Medicine Center, Shonan Kamakura General Hospital, 1370-1, Okamoto, Kamakura, Kanagawa, 247-8533, Japan

    Chikamasa Ichita

  2. Department of Health Data Science, Yokohama City University, 22-2, Seto, Kanazawa-ku, Yokohama, Kanagawa, 236-0027, Japan

    Chikamasa Ichita, Tadahiro Goto & Sayuri Shimizu

  3. TXP Medical Co., Ltd., 41-1 H1O Kanda 706, Kanda Higashimatsushita-cho, Chiyoda-ku, Tokyo, 101-0042, Japan

    Tadahiro Goto

  4. Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-0033, Japan

    Tadahiro Goto

Authors
  1. Chikamasa Ichita
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tadahiro Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sayuri Shimizu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CI designed and drafted this manuscript. TG and SS revised it.

Corresponding author

Correspondence to Chikamasa Ichita.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest directly relevant to the content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ichita, C., Goto, T. & Shimizu, S. Considerations for evaluating antibiotic prophylaxis in cirrhotic patients with upper gastrointestinal bleeding in real-world data. J Gastroenterol 59, 160–161 (2024). https://doi.org/10.1007/s00535-023-02066-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-023-02066-8

Search

Navigation